Literature DB >> 9543278

Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.

J Ashitani1, H Mukae, M Nakazato, T Ihi, H Mashimoto, J Kadota, S Kohno, S Matsukura.   

Abstract

Human neutrophils contain three isoforms of antimicrobial and cytotoxic peptides in the azurophil granules, which belong to a family of mammalian neutrophil peptides named defensins. Here we investigate the role of these peptides in diffuse panbronchiolitis (DPB). Defensins (human neutrophil peptide-1, -2 and -3) were measured by radioimmunoassay in bronchoalveolar lavage fluid (BALF) of 30 patients with DPB, 16 patients with idiopathic pulmonary fibrosis (IPF) and 15 healthy adults. The concentration of defensins was higher in BALF of patients with DPB than in patients with IPF and healthy subjects. DPB and IPF patients also had significantly higher plasma concentrations of defensins than controls. In patients with DPB, BALF concentration of defensins correlated significantly with neutrophil count or BALF concentration of interleukin (IL)-8. Immunohistochemistry of open-lung biopsy specimens from four DPB patients showed localization of defensins in neutrophils and mucinous exudate in the airways, and on the surface of bronchiolar epithelial cells. In vitro studies showed an enhanced extracellular release of defensins following stimulation of neutrophils with phorbol myristate acetate, N-formyl-methionyl-leucyl-phenyalamine, and human recombinant IL-8. Treatment of DPB with macrolides for 6 months significantly reduced neutrophil count and concentrations of defensins and IL-8 in BALF. Our results indicate accumulation of neutrophil-derived defensins in the airway in diffuse panbronchiolitis, and suggest that defensins may be a marker of neutrophil activity in this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543278     DOI: 10.1183/09031936.98.11010104

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

Review 1.  The anti-inflammatory effects of macrolides.

Authors:  D Wales; M Woodhead
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Dynamic changes in neutrophil defensins during endotoxemia.

Authors:  M E Klut; B A Whalen; J C Hogg
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 3.  Macrolides in the respiratory tract in cystic fibrosis.

Authors:  Adam Jaffé; Mark Rosenthal
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 4.  Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.

Authors:  Mohamed Zaiou
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

Review 5.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 6.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.

Authors:  T Hiratsuka; H Mukae; H Iiboshi; J Ashitani; K Nabeshima; T Minematsu; N Chino; T Ihi; S Kohno; M Nakazato
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

8.  Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs.

Authors:  Stefanos Voglis; Kieran Quinn; Elizabeth Tullis; Mingyao Liu; Melanie Henriques; Celia Zubrinich; Oscar Peñuelas; Holman Chan; Frances Silverman; Vera Cherepanov; Neil Orzech; Aye Aye Khine; André Cantin; Arthur S Slutsky; Gregory P Downey; Haibo Zhang
Journal:  Am J Respir Crit Care Med       Date:  2009-04-30       Impact factor: 21.405

9.  Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier.

Authors:  Khalil Bdeir; Abd Al-Roof Higazi; Irina Kulikovskaya; Melpo Christofidou-Solomidou; Sergei A Vinogradov; Timothy C Allen; Steven Idell; Rose Linzmeier; Tomas Ganz; Douglas B Cines
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

10.  Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.

Authors:  H Mukae; H Iiboshi; M Nakazato; T Hiratsuka; M Tokojima; K Abe; J Ashitani; J Kadota; S Matsukura; S Kohno
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.